Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley R Riddell

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host DiseaseMarie Bleakley, Alison Sehgal, Stuart Seropian, et al.
Nature Communications|January 12, 2020
Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapyAlyssa Sheih, Valentin Voillet, Laïla-Aïcha Hanafi, et al.
Blood|May 30, 2008
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBrian G Till, Michael C Jensen, Jinjuan Wang, et al.
Science (New York, N.Y.)|August 22, 2020
Designed protein logic to target cells with precise combinations of surface antigensMarc J Lajoie, Scott E Boyken, Alexander I Salter, et al.
Cancer Discovery|October 14, 2017
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T CellsJuliane Gust, Kevin A Hay, Laïla-Aïcha Hanafi, et al.
Blood|February 21, 2020
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failureJordan Gauthier, Alexandre V Hirayama, Janaki Purushe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Blood|September 28, 2019
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myelomaMargot J Pont, Tyler Hill, Gabriel O Cole, et al.
Cancer Cell|January 9, 2024
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapiesErica T Goddard, Miles H Linde, Shivani Srivastava, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host DiseaseMarie Bleakley, Alison Sehgal, Stuart Seropian, et al.
Nature Communications|January 12, 2020
Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapyAlyssa Sheih, Valentin Voillet, Laïla-Aïcha Hanafi, et al.
Blood|May 30, 2008
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBrian G Till, Michael C Jensen, Jinjuan Wang, et al.
Science (New York, N.Y.)|August 22, 2020
Designed protein logic to target cells with precise combinations of surface antigensMarc J Lajoie, Scott E Boyken, Alexander I Salter, et al.
Cancer Discovery|October 14, 2017
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T CellsJuliane Gust, Kevin A Hay, Laïla-Aïcha Hanafi, et al.
Blood|February 21, 2020
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failureJordan Gauthier, Alexandre V Hirayama, Janaki Purushe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Blood|September 28, 2019
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myelomaMargot J Pont, Tyler Hill, Gabriel O Cole, et al.
Cancer Cell|January 9, 2024
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapiesErica T Goddard, Miles H Linde, Shivani Srivastava, et al.
Pageof 18